VanEck Biotech ETF(BBH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BBH VanEck Biotech ETF

Trading 09-18 11:09:10 EDT

234.59

-2.13

-0.90%

High237.15	Low234.59	Vol1.08K
Open237.15	D1 Closing236.72	Amplitude1.08%
Mkt Cap470.71M	Tradable Cap470.71M	Total Shares2.01M
T/O254.18K	T/O Rate0.05%	Tradable Shares2.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":234.59,"timestamp":1789744111298,"preClose":236.72,"halted":0,"volume":1077,"delay":0,"changeRate":-0.008997972287935094,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":-2.13,"latestTime":"09-18 11:09:10 EDT","open":237.145,"high":237.145,"low":234.59,"amount":254182.48997999998,"amplitude":0.010793,"askPrice":234.68,"askSize":200,"bidPrice":234.44,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.72,"sharesOutstanding":1976503,"nav":231.19491,"aum":487012772.66,"dividendRate":0.00404,"bidAskSpread":0.001112,"preHourTrading":{"tag":"盘前","latestPrice":236.72,"preClose":236.72,"latestTime":"04:00 EDT","volume":1,"amount":236.72,"timestamp":1789718407582,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":236.72,"preClose":236.72,"latestTime":"19:30 EDT","volume":21,"amount":4970.46,"timestamp":1789687802811,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.208789,"impliedVol":0.1888,"impliedVolPercentile":0.3865},"requestUrl":"/m/hq/s/BBH/tweets","defaultTab":"tweets","newsList":[{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU2468319806.SGD","SG9999001176.SGD","IDNA","LU0432979614.USD","BK4567","LU2236285917.USD","IE0002270589.USD","LU2362540622.SGD","LU1674673691.USD","IE00B894F039.SGD","BK4139","LU1035775433.USD","LU2462157665.USD","SGXZ57979304.SGD","BBH","LU1778281490.HKD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0079474960.USD","IBBQ","LU1815336091.USD","LU2089984988.USD","LU0058720904.USD","IE0009355771.USD","IBB","LU0757428866.USD","PBE","IE00B19Z9Z06.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4532","LU1430594728.SGD","LU2362541513.USD","LU0109394709.USD","BIB","VRTX","GNMX","SG9999001176.USD","IE00BJT1NW94.SGD","SG9999013999.USD","LU1069344957.HKD","LU1559883803.SGD","BK4585","LU0889565916.HKD","LU2237438978.USD","TBXU","VERX","BK4533","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0417517546.SGD","LU1093756325.SGD","LU1674673428.USD","GNMX","SG9999013999.USD","PBE","LU2468319806.SGD","LU2417539215.USD","TBXU","IE00B4R5TH58.HKD","IE0002270589.USD","SGXZ57979304.SGD","BBH","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU0256863811.USD","BK4139","LU0432979614.USD","LU2362541513.USD","VRTX","SG9999001176.USD","LU1585245621.USD","IBB","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU2456880835.USD","LU2462157665.USD","LU0823416689.USD","SG9999001176.SGD","LU1430594728.SGD","IE00B894F039.SGD","LU2236285917.USD","IBBQ","IE00BJT1NW94.SGD","LU0058720904.USD","LU2362541273.HKD","LU0079474960.USD","BK4567","BK4585","LU2324357040.USD","LU2237438978.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","BIB","BK4588","IDNA","BK4532","LU0109394709.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BBH","LU0109394709.USD","BIB","LU1057294990.SGD","LU1585245621.USD","BK4583","LU1037948897.HKD","LU1674673691.USD","LU1061106388.HKD","TBXU","TMED","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU0234570918.USD","BK4550","LU0965509010.AUD","LU2087621335.USD","LU0889565916.HKD","MEDI","LU1066053197.SGD","GILD","IBBQ","LU0861579265.USD","LU2112291526.USD","IE0002270589.USD","LU2324357040.USD","BK4578","IE00B7SZLL34.SGD","LU0882574055.USD","LU1934455277.USD","LU0320765992.SGD","LU0289739699.SGD","LU2089984988.USD","LU0823416689.USD","BMED","LU0965508806.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1023059063.AUD","SG9999015952.SGD","BK4139","SG9999015978.USD","IE00B19Z3B42.SGD","LU1674673428.USD","BK4585","BK4532","LU0965509283.SGD","LU0114720955.EUR","LU2468319806.SGD","SG9999015986.USD","BK4568","IBB","LU0965509101.SGD","BK4566","LU1066051498.USD","LU1571399168.USD","LU1430594728.SGD","LU0058720904.USD","LU0122379950.USD","LU1839511570.USD","SG9999015945.SGD","LU1778281490.HKD","LU0859254822.USD","LU1934455194.USD","LU2357627491.SGD","LU1934455863.HKD","LU1037948541.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","MRNY","IBBQ","LU0965509101.SGD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","GNOM","LGHT","SG9999015945.SGD","LU0859254822.USD","LU0320765992.SGD","MRNA","SG9999015986.USD","LU0823416689.USD","LU2324357040.USD","WDNA","LU2089984988.USD","LU0114720955.EUR","LU0965509010.AUD","LU0882574055.USD","BBH","IDNA","BIB","BK4566","LU1934455863.HKD","LU1037948897.HKD","LU2357627491.SGD","LU0289739699.SGD","BK4568","IE00BSNM7G36.USD","LU1585245621.USD","MRNX","BK4551","IBB","LU0234570918.USD","LU0122379950.USD","LU0889565916.HKD","BK4578","LU1839511570.USD","TMED","LU1674673428.USD","BK4501","MEDI","IE00B7SZLL34.SGD","GILD","LU0861579265.USD","BK4534","LU1778281490.HKD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4139","PJP","BBH","BK4533","LU2089984988.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU1061106388.HKD","LU1571399168.USD","LU2468319806.SGD","IBBQ","LU0058720904.USD","BK4199","LU0122379950.USD","LU1057294990.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","BIB","BK4585","BK4534","BK4581","ITP","LU2242646821.SGD","AMGN","LU0109394709.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0868494617.USD","IE00B4R5TH58.HKD","PBE","IE00BJJMRZ35.SGD","TBXU","IBB","SG9999001440.SGD","LU2242652126.USD","BK4566","IE0002141913.USD","LU2112291526.USD","LU1983299246.USD","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","IE00BJT1NW94.SGD","BBH","LU0058720904.USD","BIB","IE00B4R5TH58.HKD","IE0002141913.USD","LU0128526141.USD","BK4530","LU2089984988.USD","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4533","BK4121","LU0390134368.USD","LU1983299246.USD","IBBQ","IBB","LU0889565916.HKD","LU1815336091.USD","LU0122379950.USD","LU0868494617.USD","LU0320765992.SGD","XLV","LU2468319806.SGD","IE0009355771.USD","PBE","HCSG","BK4534","BK4139","BK4585","LU1057294990.SGD","PJP","BK4137","AMGN","LU0757428866.USD","SG9999001440.SGD","CRL","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LABU","IE00BFMHRM44.USD","BK4581","XBI","LU2112291526.USD","BK4566","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU2468319806.SGD","LU0432979614.USD","XLV","LU2362540622.SGD","BK4599","SYK","XBI","IHI","ATRC","BBH","IE0002141913.USD","LU0868494617.USD","BK4581","IBBQ","LU0882574055.USD","LU0128526141.USD","LU2404859667.USD","LU0528227936.USD","LU2089984988.USD","LU2506951875.HKD","LU0058720904.USD","LU0690374961.EUR","IBB","BK4534","LU0690374615.EUR","LU2506952097.USD","PBE","LU0823417653.USD","BK4082","LU2362541513.USD","LU0109394709.USD","LU2404859741.USD","BIB","BK4588","LU1061106388.HKD","LU1571399168.USD","GB00B4QBRK32.GBP","GB00B4LPDJ14.GBP","AMGN","HCSG","IE00BJT1NW94.SGD","LABU","LU0029874061.USD","LU2242652126.USD","BK4585","LU2362541273.HKD","BK4566","TBXU","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","COPP","IBB","LU0823416689.USD","LU2236285917.USD","CPER","BBH","CPXR","LU0432979614.USD","UYM","LU2417539215.USD","LU0566484027.USD","XME","IE0002270589.USD","VERX","LU2324357040.USD","BK4532","IE00B19Z9Z06.USD","TBXU","LU1093756168.USD","LU1035775433.USD","IBBQ","ICOP","BIB","COPJ","LU2462157665.USD","LU1430594728.SGD","LU0256863811.USD","BK4023","IE00B2B36J28.USD","LU1069344957.HKD","BK4139","VRTX","IE0009355771.USD","QCmain","GNMX","IE00B894F039.SGD","SG9999013999.USD","PBE","IE00BFTCPJ56.SGD","LU1778281490.HKD","IDNA","LU2089984988.USD","MHGmain","LU0889565916.HKD","LU2237438978.USD","LU2468319806.SGD","LU1093756325.SGD","LU0320765992.SGD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0882574055.USD","LU1674673691.USD","LU0289739699.SGD","LU0823416689.USD","IBB","LU1674673428.USD","LU1778281490.HKD","BK4532","IE00B19Z3581.USD","BK4568","BK4588","LU1023059063.AUD","BK4585","LU0234570918.USD","LU0859254822.USD","LU1066051498.USD","IE00B19Z3B42.SGD","SG9999015986.USD","TMED","IE00B3T34201.USD","IE00BKVL7J92.USD","TBXU","BIB","GILD","LU0965509101.SGD","BK4566","MEDI","LU0109394709.USD","LU0122379950.USD","LU1057294990.SGD","LU2087621335.USD","BK4578","BBH","LU0320765992.SGD","LU2357627491.SGD","LU2468319806.SGD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","BMED","IE0002270589.USD","BK4550","LU0114720955.EUR","LU1430594728.SGD","SG9999015945.SGD","IBBQ","LU0965509283.SGD","LU1585245621.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU1934455277.USD","LU2324357040.USD","LU0058720904.USD","LU2112291526.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0882574055.USD","IBBQ","LU0861579265.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","SG9999015945.SGD","LU0122379950.USD","LU1066053197.SGD","IE00BKVL7J92.USD","TBXU","LU1934455863.HKD","LU2357627491.SGD","LU0234570918.USD","LU0109394709.USD","LU0965509101.SGD","TMED","LU1571399168.USD","LU1061106388.HKD","GILD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965509283.SGD","LU1057294990.SGD","LU1037948897.HKD","IBB","SG9999015978.USD","LU0823416689.USD","LU1037948541.HKD","BIB","LU1023059063.AUD","LU0859254822.USD","BBH","LU2089984988.USD","LU1585245621.USD","LU1839511570.USD","BK4550","BK4566","LU0965509010.AUD","LU2087621335.USD","MEDI","BMED","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","XLV","BK4581","IDNA","LU0289739699.SGD","BK4585","LU2237438978.USD","LU0061475181.USD","TBXU","VERX","LU2362541273.HKD","BBH","LU1585245621.USD","LU1778281490.HKD","LU1093756325.SGD","LABU","IE00BJJMRZ35.SGD","LU2324357040.USD","LU1069344957.HKD","BIB","IE00BZ9MQY76.HKD","IE00B894F039.SGD","LU2362540622.SGD","LU1559883803.SGD","LU1674673428.USD","IE0009355771.USD","LU0029874061.USD","LU2417539215.USD","CRL","MEDI","IBBQ","ASND","LU2462157665.USD","BK4533","VRTX","XBI","LU0889565916.HKD","LU1093756168.USD","IBB","LU0390134368.USD","SGXZ57979304.SGD","LU2236285917.USD","HCSG","PBE","BK4588","LU1035775433.USD","BK4023","LU1430594728.SGD","LU0757428866.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LU2242649171.HKD","LU0345774391.USD","SKHZ","BK4561","LU2054465674.USD","IE00BLSP4239.USD","LU0133085943.USD","LU0719512351.SGD","BKNU","LU0943347566.SGD","XNTK","BK4566","LU0256863811.USD","IE000SO60NU8.SGD","LU2552382132.HKD","IE000MB6IJN5.SGD","LU0265550359.USD","AZNH","LU1852331112.SGD","LU2456880835.USD","LU2237443549.SGD","LU0251132253.USD","AMDY","LU2168564149.EUR","AMDW","LU2764262908.HKD","BK4141","LU1861220033.SGD","LU0823434740.USD","LU1861558580.USD","LU1430597077.USD","LU2087621335.USD","LU2381873111.SGD","WISE","LU0058720904.USD","LU0154236417.USD","IE00BMPRXR70.SGD","IE00BWXC8680.SGD","LU1032466523.USD","SAMD0main","BK4534","IE00BLSP4452.SGD","LU0211326839.USD","LU1064131342.USD","CHAT","IE00BYXW3230.USD","IE0034235188.USD","LU0077335932.USD","LU0965509283.SGD","LU0496365809.HKD","AMYY","LU2236285917.USD","SGXZ23171101.USD","LU0889566641.SGD","LU0823434583.USD","LU1084165304.USD","LU2108987350.USD","LU2290526834.HKD","LU1057294990.SGD","LU0787776722.HKD","LU2098885051.SGD","LU0048573561.USD","LU0029864427.USD","WUGI","LU0345770308.USD","LU0127658192.USD","LU0976567544.SGD","BK4614","IE00B775SV38.USD","BMED","LU0320765646.SGD","LU2860962120.EUR","LU1974910355.USD","IE00BQXX3C00.GBP","IBBQ","BK4520","LU0345769631.USD","LU0114720955.EUR","SG9999015986.USD","BIB","LU0654597011.USD","IE00BFXG1179.USD","LU2237957811.SGD","SINTCmain","TROW","LU1244550221.USD","LU2213496289.HKD","LU1023059063.AUD","LU0942090050.USD","LU2746668461.USD","LU2430703095.HKD","LU1267930813.SGD","LU1674673691.USD","IBB","LU0882574055.USD","DRIV","LU2237957902.USD","LU0792757196.USD","LU0109394709.USD","LU0323591593.USD","MEDI","LU2177674079.SGD","LU1366192091.USD","LU2023250330.USD","IE0000B7K699.USD","BK4512","LU1232071149.USD","TFNS","IE0034235295.USD","IE00BK4W5M84.HKD","HK0000304797.USD","IE0034235303.USD","FTXL","LU0109392836.USD","LU0187121727.USD","AIQ","AMDU","LU2750360641.GBP","CHPS","LU2461242641.AUD","LU1366333091.USD","LU0203347892.USD","BK4533","LU2168564065.EUR","SKHYV","LU0823413660.USD","BAI","BK4139","GDX","LU1720051017.SGD","LU2168564495.EUR","SGXZ51526630.SGD","SOXX","LU0823416689.USD","SIL","SKHX","LU2357305700.SGD","LU1914381329.SGD","LU0056508442.USD","LU1242518931.SGD","LU1150488135.SGD","LU0070302665.USD","LU1989772840.SGD","LU0390134368.USD","LU1988902786.USD","GLDN","LU0128525929.USD","LU0868494708.USD","SOXY","LEGR","LU0964807845.USD","LU0965509101.SGD","AMDS","LU1551013342.USD","ARTY","IE00BMPRXQ63.HKD","LU2764263203.CNY","LU0266013472.USD","HK0000304805.HKD","LU2471134523.USD","BK4581","LU0265550946.USD","LU2089984988.USD","LU1956131251.USD","AMUU","LU1829250122.USD","SKHY","SKHA","FNV","LU2756315318.SGD","LU0106831901.USD","BK4232","JPM","LU0208291251.USD","LU2592432038.USD","IE00BQXX3F31.USD","INTW","IE00BK4W5L77.USD","LU0225283273.USD","LU2360107168.USD","LU2458330169.SGD","04335","LU0823421416.USD","LU0210536198.USD","LU1839511570.USD","LU2746668974.SGD","LU0081259029.USD","DAMD","LU0708994859.HKD","LU2505996509.AUD","SKUU","SILJ","BK4583","LU1043141123.HKD","BK4529","LU2087625088.SGD","IE0001KFT4U8.USD","LU0251131958.USD","07709","LU1316542783.SGD","IE00B5949003.HKD","LU0889565916.HKD","LU2361044865.SGD","FNCL","BK4573","LU2458330243.SGD","LU0861579265.USD","LU1548497426.USD","LU0823397285.USD","LU1121112475.USD","BBH","LU0823413587.USD","LU2112291526.USD","LU1145028129.USD","LU2361044949.HKD","IE000BZT7R73.USD","LU1043141396.HKD","LU2430703178.SGD","LU0106261372.USD","BK4135","LU2505996681.GBP","QQQA","BKNG","IE00BZ1G4Q59.USD","LU1894683348.USD","BK4588","LU1934455863.HKD","BK4022","LU1236620750.USD","TMED","LU2756315664.SGD","LU0274383776.USD","IXG","LU0353189763.USD","INTC","BK4578","LU0642271901.SGD","GILD","AWAY","LU0234570918.USD","IE000WAW04H5.SGD","LU0321505439.SGD","LU1934455194.USD","LU2931357623.SGD","LU0321505868.SGD","LU0979878070.USD","LU1037948897.HKD","LU2896262040.SGD","LU1861559042.SGD","LU0289739699.SGD","LU1037948541.HKD","LU1778281490.HKD","BK4515","LU0683600562.USD","IE0002270589.USD","IE00BKDWB100.SGD","LU2237443978.SGD","LU2355687059.USD","LU0211328371.USD","LU0965508806.USD","LU1261432733.SGD","LU2250418816.HKD","LU1629891620.HKD","LU2023250843.SGD","SMH","SG9999015952.SGD","LU2237443382.USD","LU1989764748.USD","LU2168564222.USD","SKHU","BK4007","LU1242518857.USD","LU1720051108.HKD","LU0345770993.USD","LU1162221912.USD","JPMO","SG9999002232.USD","LU1894683264.USD","TBXU","IE00BQXX3D17.EUR","IE00B19Z3581.USD","LU0742534661.SGD","IE00B3S45H60.SGD","LU2462157665.USD","LU0310799852.SGD","LU2750360997.AUD","LU0882574139.USD","LU0689472784.USD","SKDD","SG9999001424.SGD","IE00B1BXHZ80.USD","AMD","LU1116320901.HKD","LU1880398471.USD","LU0426412945.USD","LU2360106780.USD","FTXO","SLVR","BK4585","AMDG","LU0203345920.USD","LU2471134796.USD","IE00BJLML261.HKD","INT","IE00B19Z3B42.SGD","TRUF","LU0823411888.USD","BK4568","LU0426417589.USD","LU1804176565.USD","BK4550","LU2168563687.JPY","SG9999004303.SGD","LU0238689110.USD","SGXZ99366536.SGD","WNDR","LU0267386448.USD","LU1303367103.USD","IE00BKVL7J92.USD","LU1496350171.SGD","BK4532","BK4017","USXF","LU2237443622.USD","GOAU","IE000F7OJYX1.SGD","SGXZ81514606.USD","IE00B7SZLL34.SGD","LU1923623000.USD","IETC","LU2471134879.HKD","LU1066051498.USD","LU1951200564.SGD","LU0557290698.USD","IE00B3T34201.USD","LU0097036916.USD","LU2264538146.SGD","LU1670628061.USD","LU2106854487.HKD","LU1119994496.HKD","LU2148611432.USD","LU2008162690.USD","LU0994945656.USD","LU2265009873.SGD","INYY","LU1244550577.SGD","LU1061106388.HKD","LU1917777945.USD","LU1699723380.USD","IE00BN8TJ469.HKD","LU1267930490.SGD","IE00BMPRXN33.USD","LU1150488218.USD","LU0320765489.SGD","BK4548","SKHQ","SG9999001440.SGD","IYG","JBHT","LU0859254822.USD","TTEQ","SKHL","LU2089985449.USD","LU1803068979.SGD","BK4207","PSI","LU1668664300.SGD","BK4504","LU2430703251.USD","LU2237443465.HKD","BK4535","LU2417539215.USD","FAI","IE00BJTD4N35.SGD","AMDC","LU0170899867.USD","LU2361045086.USD","BK4575","LU1496350502.SGD","LU0215105999.USD","LU0965509010.AUD","IE000M9KFDE8.USD","SKHN","LU0316494557.USD","SG9999015945.SGD","BK4612","LU1116320737.USD","LU1880398554.USD","BK4516","LU1363072403.SGD","LU0251142724.SGD","LU2097829019.USD","LU0149725797.USD","BK4567","HYNX","LU0211327993.USD","KBWB","BK4554","LU0612318385.USD","LU0823421333.USD","LU0971096721.USD","LU2468319806.SGD","BK4543","LU2357627491.SGD","BK4605","LU0157215616.USD","LU0640476718.USD","LU2543165471.USD","LU0820561909.HKD","IE00B5TLWC47.USD","LU0310800379.SGD","LU2247934214.USD","LINT","JPO","GAMR","LU1267930573.SGD","LU0353189680.USD","LU1670627923.USD","CNAV","IE00BDCRKT87.USD","LU0082616367.USD","LU0198837287.USD","AIS","LU1551013425.SGD","AMDL","LU0823397103.USD","LU2237443895.HKD","LU1989764664.SGD","LU0320765992.SGD","LU2324357040.USD","UYG","BK4579","LU2471134952.CNY","BK4527","LU0122379950.USD","LU0889565833.HKD","LU2720916845.USD","LU1989772923.USD","LU0048584097.USD","ILDR","SMHX","LU1674673428.USD","SK","LU0006306889.USD","AMDD","IE00BSNM7G36.USD","LU0174119429.USD","IE00B1XK9C88.USD","LU0211331839.USD","TEK","LU1571399168.USD","IE00BHPRN162.USD","LU0786609619.USD","AUAU","LU1430594728.SGD","LU0345769128.USD","LU1280957306.USD","BK4602","IE00BDRTCR15.USD","LU2552382215.SGD","FMTL","LU0256863902.USD","LU2552382058.USD","LU0868494617.USD","LU2211815571.USD","VFH","LU0612318971.USD","LU0820562030.AUD","LU0234572021.USD","WPM","IE00BJTD4V19.USD","LU1585245621.USD","LU1066053197.SGD","LU0345774631.USD","IE0009356076.USD","LU1244550494.USD","LU2244417387.USD","LU2764263039.SGD","IYF","LU0820561818.USD","BK4142","TRFK","SG9999015978.USD","LU1934455277.USD","LU1951198990.SGD","LU1861215975.USD","IE0004445239.USD","LU2462591350.SGD","LU0417517546.SGD","LU1236620834.HKD","XLF","LU2023250504.SGD","SG9999002224.SGD","LU0211326755.USD","IE00BBT3K403.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0058720904.USD","LU2242652126.USD","LU1023059063.AUD","LU0122379950.USD","LU0289739699.SGD","LU1983299246.USD","LU2468319806.SGD","BK4581","LU1061106388.HKD","PJP","IBB","BK4139","LU0320765992.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","BK4533","IBBQ","BK4585","BK4599","BK4588","LU2242646821.SGD","TBXU","VRDN","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4534","PBE","IE00BJT1NW94.SGD","BK4566","LU0889565916.HKD","AMGN","LU2089984988.USD","IE0002141913.USD","SG9999001440.SGD","BIB","LU2112291526.USD","LU0868494617.USD","BBH","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU0122379950.USD","LU1585245621.USD","BIB","SG9999015978.USD","IBB","LU1057294990.SGD","LU2087621335.USD","LU2357627491.SGD","BK4532","LU1066051498.USD","TMED","BK4550","TBXU","BK4568","LU0058720904.USD","LU1778281490.HKD","LU0965509283.SGD","BK4583","LU0234570918.USD","SG9999015986.USD","LU1037948541.HKD","LU2468319806.SGD","LU1674673691.USD","LU2112291526.USD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BBH","LU0823416689.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1934455194.USD","LU0889565916.HKD","BK4578","BMED","IBBQ","LU1934455277.USD","LU0965509010.AUD","LU1839511570.USD","LU1066053197.SGD","SG9999015945.SGD","LU1037948897.HKD","GILD","MEDI","LU1061106388.HKD","LU1430594728.SGD","LU2089984988.USD","LU0320765992.SGD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0432979614.USD","LU1670711040.USD","LU2125154778.USD","LU1585245621.USD","IHE","PJP","LU1093756168.USD","BK4581","LU0114720955.EUR","LU1023059063.AUD","BK4532","LU0882574055.USD","LU2112291526.USD","LU0225771236.USD","LU2468319806.SGD","BK4559","LU0289739699.SGD","LU1093756325.SGD","LU0058720904.USD","IBB","IE0002141913.USD","LU1868837300.USD","BK4533","PBE","IE00BFXG1179.USD","LU0225284248.USD","LU0306807586.USD","BMY","LU2242646821.SGD","LU0889565916.HKD","LU2089984988.USD","BK4139","LU0267386448.USD","LU1236620750.USD","LU2242652126.USD","LU0122379950.USD","LU2596442595.SGD","LU0985481810.HKD","BK4599","LU1670710661.SGD","LU1883839398.USD","LU2133065610.SGD","LU1057294990.SGD","BK4585","FTXH","IE00BJJMRZ35.SGD","LU0321505868.SGD","LU0237698245.USD","IE0009355771.USD","LU1236620834.HKD","AMGN","LU1989771016.USD","LU0320765992.SGD","04332","LU0456855351.SGD","LU1868837136.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU1261432733.SGD","LU1061106388.HKD","LU0321505439.SGD","LU0868494617.USD","LU1868836591.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU2125154935.USD","BK4588","BIB","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1670711123.USD","LU1868836914.USD","LU1032466523.USD","TBXU","LU1074936037.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU1323610961.USD","LU2360032135.SGD","LU0306806265.USD","LU1868836757.USD","BK4534","IBBQ","BK4566","LU1718418525.SGD","LU0061475181.USD","BBH","LU1571399168.USD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU1670710588.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621483","title":"Revolution Medicines gets orphan designation for pancreatic cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621483","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621483?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:00","pubTimestamp":1789498813,"startTime":"0","endTime":"0","summary":"The FDA granted Revolution Medicines (RVMD)’ zoldonrasib orphan designation as a treatment of pancreatic cancer. Published first on TheFly – the ul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BK4588","IE00B2B36J28.USD","BK4585","PTH","IE0002141913.USD","LU0320765992.SGD","IDNA","LU0109394709.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BBH","LABU","CANC","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0009354923.USD","LU0889565916.HKD","BK4139","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","LU0320765992.SGD","LU1934455863.HKD","TBXU","IE00BKVL7J92.USD","LU0859254822.USD","LU0109394709.USD","LU1023059063.AUD","LU1934455277.USD","SG9999015952.SGD","BIB","BK4568","LU1778281490.HKD","BK4585","LU0965509010.AUD","IE00B19Z3581.USD","LU0114720955.EUR","IE0002270589.USD","LU0234570918.USD","BK4588","LU0965508806.USD","LU2112291526.USD","LU1037948541.HKD","BMED","BK4566","IE00B19Z3B42.SGD","LU1571399168.USD","LU0965509283.SGD","LU1674673691.USD","IBB","GILD","LU0882574055.USD","LU1037948897.HKD","LU1430594728.SGD","MEDI","TMED","SG9999015986.USD","IE00B3T34201.USD","LU1674673428.USD","BBH","LU0861579265.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","BK4550","LU0122379950.USD","LU0823416689.USD","IBBQ","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","LU1066051498.USD","LU2089984988.USD","LU0965509283.SGD","LU1061106388.HKD","TBXU","IE0002270589.USD","GILD","LU0058720904.USD","IBB","LU0289739699.SGD","TMED","BK4585","SG9999015945.SGD","IBBQ","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1585245621.USD","LU0859254822.USD","LU1037948541.HKD","LU0114720955.EUR","LU1934455863.HKD","SG9999015952.SGD","LU1430594728.SGD","BK4566","LU1066053197.SGD","BK4583","LU1571399168.USD","LU2324357040.USD","BK4568","SG9999015986.USD","BK4532","LU0234570918.USD","LU0861579265.USD","BIB","BK4550","LU1674673428.USD","LU1778281490.HKD","MEDI","LU1023059063.AUD","BK4578","LU0965509010.AUD","BBH","BK4588","BMED","LU1674673691.USD","LU0965509101.SGD","IE00B3T34201.USD","LU2468319806.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2357627491.SGD","IE00B19Z3581.USD","BIB","IE00B19Z3B42.SGD","LU0861579265.USD","LU1585245621.USD","LU0859254822.USD","LU2324357040.USD","LU0823416689.USD","GILD","LU0965509283.SGD","TMED","LU1066053197.SGD","TBXU","LU0965509010.AUD","BMED","LU1430594728.SGD","SG9999015945.SGD","LU0889565916.HKD","LU1674673691.USD","LU2089984988.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4532","BK4578","LU0882574055.USD","SG9999015978.USD","MEDI","IE0002270589.USD","SG9999015952.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU1778281490.HKD","LU1037948541.HKD","BK4583","LU1061106388.HKD","LU2468319806.SGD","LU0234570918.USD","LU1037948897.HKD","IBBQ","LU1057294990.SGD","BK4566","BBH","LU1571399168.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU1934455277.USD","LU1839511570.USD","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU1066053197.SGD","LU1934455277.USD","LU1571399168.USD","SG9999015945.SGD","LU0965509010.AUD","IBB","BK4585","IE0002270589.USD","LU1778281490.HKD","LU1057294990.SGD","LU2468319806.SGD","LU1061106388.HKD","MEDI","LU0114720955.EUR","BK4139","BMED","LU0965509101.SGD","TMED","BK4568","LU1066051498.USD","TBXU","LU0965508806.USD","SG9999015952.SGD","LU0289739699.SGD","IBBQ","LU0859254822.USD","GILD","IE00BKVL7J92.USD","BK4550","LU0058720904.USD","SG9999015986.USD","LU0122379950.USD","BK4588","IE00BSNM7G36.USD","BK4566","IE00B7SZLL34.SGD","LU1037948541.HKD","LU2089984988.USD","LU2324357040.USD","BIB","BK4578","IE00B3T34201.USD","LU0109394709.USD","LU1934455194.USD","LU2357627491.SGD","BK4532","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaneck.com/etf/equity/bbh/overview/","stockEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0545},{"period":"3month","weight":0.2615},{"period":"6month","weight":0.3044},{"period":"1year","weight":0.4289},{"period":"ytd","weight":0.2507}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1758},{"period":"1year","weight":0.1569},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.034474},{"month":2,"riseRate":0.533333,"avgChangeRate":-0.001737},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.001534},{"month":4,"riseRate":0.4,"avgChangeRate":0.001235},{"month":5,"riseRate":0.6,"avgChangeRate":0.01217},{"month":6,"riseRate":0.8,"avgChangeRate":0.026892},{"month":7,"riseRate":0.933333,"avgChangeRate":0.049139},{"month":8,"riseRate":0.6,"avgChangeRate":0.01477},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.01063},{"month":10,"riseRate":0.357143,"avgChangeRate":-0.00566},{"month":11,"riseRate":0.785714,"avgChangeRate":0.046381},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.017373}],"exchange":"NASDAQ","name":"VanEck Biotech ETF","nameEN":"VanEck Biotech ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VanEck Biotech ETF(BBH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VanEck Biotech ETF(BBH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VanEck Biotech ETF,BBH,VanEck Biotech ETF股票,VanEck Biotech ETF股票老虎,VanEck Biotech ETF股票老虎国际,VanEck Biotech ETF行情,VanEck Biotech ETF股票行情,VanEck Biotech ETF股价,VanEck Biotech ETF股市,VanEck Biotech ETF股票价格,VanEck Biotech ETF股票交易,VanEck Biotech ETF股票购买,VanEck Biotech ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VanEck Biotech ETF(BBH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VanEck Biotech ETF(BBH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}